Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model (Q39188098)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 February 2013
edit
Language Label Description Also known as
English
Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model
scientific article published on 26 February 2013

    Statements

    Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model (English)
    Takashi Ninomiya
    Yoshihiro Honda
    26 February 2013
    589-597

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit